PATL2新突变导致女性不育伴卵母细胞生发泡阻滞
本研究于2013年1月至2016年12月招募9例表现为卵母细胞生发泡(GV)阻滞的原发性不育女性,对PATL2编码区行Sanger测序。在9例无关患者中4例(44.4%)检出PATL2双等位基因突变,其中5个新发点突变和1个复发性剪接突变,提示PATL2突变可能导致原发性不育女性卵母细胞成熟阻滞。
要点
- 9例卵母细胞GV阻滞的原发性不育女性中4例(44.4%)检出PATL2双等位基因突变。
- 共检出5个新发点突变和1个复发性剪接突变,经生物信息学评估致病性。
- 纯合错义突变患者与无义突变患者及未确诊患者卵母细胞间无明显表型差异。
核心结论
- PATL2双等位基因突变可能解释部分原发性不育女性的卵母细胞GV阻滞,占本组9例无关患者的44.4%。
- 研究进一步证实PATL2对人类卵母细胞成熟和女性生育力是必需的,提示对卵母细胞成熟阻滞的原发性不育女性检测PATL2突变具有潜在预后价值。
研究设计与样本
- 本研究于2013年1月至2016年12月在早期补救ICSI或ICSI治疗期间招募9例无关的原发性不育女性,均表现为卵母细胞GV阻滞。
- 从全部9例患者及其可获取的家系成员血样中提取基因组DNA,对PATL2全部编码区行Sanger测序,并用生物信息学方法评估变异致病性及对蛋白的可能影响。
主要发现
- 在9例无关患者中4例(44.4%)检出PATL2突变,包括5个新发点突变和1个复发性剪接突变。
- 发现一个近亲婚配家系,两名患病姐妹携带纯合错义突变,其能生育的兄弟亦携带该突变。
- 纯合错义突变患者、无义突变患者与未确诊患者之间卵母细胞未见明显表型差异。
临床怎么用
- 作者认为,对卵母细胞成熟阻滞的原发性不育女性检测PATL2突变具有潜在预后价值。
局限性
- PATL2的功能仍 largely 未知。
- 突变PATL2导致人类卵母细胞成熟阻滞的确切致病机制及克服该状况的策略尚需在未来进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do PATL2 mutations account for female infertility with oocyte germinal vesicle (GV) arrest? SUMMARY ANSWER: Four of nine independent families with oocyte GV arrest were identified with biallelic PATL2 mutations, suggesting that these mutations may be responsible for oocyte maturation arrest in primary infertile women. WHAT IS KNOWN ALREADY: Recently, two independent studies have demonstrated that infertility in some women with oocyte maturation arrest at the GV stage was caused by biallelic mutations in PATL2. PATL2 encodes protein PAT1 homolog 2, an RNA-binding protein that may act as a translational repressor. STUDY DESIGN, SIZE, DURATION: In this study, nine unrelated primary infertile females presenting with oocyte GV arrest were recruited during the treatment of early rescue ICSI or ICSI from January 2013 to December 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Genomic DNA was isolated from blood samples obtained from all nine affected individuals and all of their available family members. All the coding regions of PATL2 were sequenced by Sanger sequencing. The pathogenicity of the identified variants and their possible effects on the protein were evaluated in silico. MAIN RESULTS AND THE ROLE OF CHANCE: Five novel point mutations and one recurrent splicing mutation in PATL2 were identified in four of nine (44.4%) unrelated patients. We found a consanguineous family with a homozygous missense mutation in two affected sisters, and their fertile brother. There were no clear phenotypic differences in oocytes between the patient with the homozygous missense mutation, patients with nonsense mutations and undiagnosed patients. LARGE SCALE DATA: n/a. LIMITATIONS, REASONS FOR CAUTION: The function of PATL2 remains largely unknown. Both the exact pathogenic mechanism(s) of mutated PATL2 causing human oocyte maturation arrest and the strategies to overcome this condition should be further investigated in the future. WIDER IMPLICATIONS OF THE FINDINGS: According to our data, mutations in PATL2 account for 44.4% of the individuals with oocyte GV arrest. Our study further confirms that PATL2 is required for human oocyte maturation and female fertility, which indicates a potential prognostic value of testing for PATL2 mutations in primary infertile women with oocyte maturation arrest. STUDY FUNDING/COMPETING INTEREST(S): Natural Science Foundation of Anhui Province (1808085MH241), National Natural Science Foundation of China (81401251 and 81370757) and Central Guided Local Development of Science and Technology Special Fund (2016080802D114) supported this study. None of the authors have any competing interests.
引用
- Huang L, Tong X, Wang F, et al. Novel mutations in PATL2 cause female infertility with oocyte germinal vesicle arrest. Hum Reprod. 2018. PMID: 29697801. doi:10.1093/humrep/dey100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。